Abstract Library

#2856 Pattern of Disease Recurrence and Treatment after Radical Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PanNET)

Introduction: The risk of recurrence after radical surgery performed for pancreatic neuroendocrine tumors (PanNET) is reported between 10 and 30%. Nowadays, no adjuvant therapy is recommended for these patients and specific treatments are offered only when recurrence occurs. Nevertheless, among the available systemic and locoregional treatments, there are no specific recommendations on which the best option could be for treating recurrent disease.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Andreasi V

Authors: Andreasi V, Partelli S, Landoni L, Nessi C, Muffatti F,

Keywords: pancreatic neuroendocrine tumors, recurrence, surgery, locoregional treatment, systemic treatment,

#1677 A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Non-Functional Pancreatic Neuroendocrine Tumors.

Introduction: Surgical resection is the preferred treatment for NF-pNET, however recurrence still occurs frequently after curative surgery, worsening prognosis of patients.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Genc C

Authors: Genc C, Jilesen A, Partelli S, Falconi M, Muffatti F,

Keywords: pNET, recurrence, predictive-model.,

#1567 Pancreatic Neuroendocrine Tumors: Experience from a Single Institute

Introduction: A dedicated multidisciplinary team is necessary in the management of pancreatic neuroendocrine tumor (pNET).

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Caff A, Cordio S, Pellegriti G, Russo M, Trovato M,

Keywords: pancreatic, Ki-67,

#1267 Two Cases of Parathyroid Cancer with Pulmonary Metastasis

Introduction: Parathyroid cancer(PC) is a rare disease accounting for less then 1% of all patients with primary hyperparathyroidism. The prognosis of patients with parathyroid carcinoma is variable; more than 50% have a persistent or recurrent disease due to a regional or distant disease.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Voronkova I, Gurevich L, Pigarova E, Rojinskaya L,

Keywords: Parathyroid cancer, primary hyperparathyroidism,

#1050 Recurrent Disease After Curative Pancreatic Resection for Patients with Non-Functional Neuroendocrine Tumor; Identify the High Risk Patient

Introduction: Since the overall favourable survival, detection of recurrent disease is one of the main goals during follow up in patients with resected pancreatic neuroendocrine tumors (pNET).

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Jilesen A

Authors: Jilesen A, Van Eijck C, Van Kemenade F, Van Eeden S, Verheij J,

Keywords: NF,